FDA Inspection 973313 — Northern Illinois Blood Bank Inc.
The FDA completed an inspection of Northern Illinois Blood Bank Inc. on May 25, 2016 in Belvidere, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 25, 2016
- Fiscal Year
- 2016
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Belvidere, IL (United States)